Medicinal cannabis is all the craze right now, and we are here to give you an overview of what medical conditions it treats and how it affects our bodies.
Medical Cannabis is defined as the dry flower or Cannabinoid chemical extracts such as cannabidiol (CBD) or tetrahydrocannabinol (THC). Doctors typically prescribe oils (tinctures), patches or oral sprays suited to the patient. Medical marijuana treats illnesses, mental disorders and diseases.
People suffering from chronic illness in which conventional medicine has not worked, or has worked less effectively, can request alternative treatment such as medicinal marijuana to their doctor.
In some cases, conventional medicine may not work or is cause debilitating side effects. Cannabis can help to relieve symptoms in the case for patients receiving chemotherapy or pain relief in disorders such as fibromyalgia.
One of the most common inquiries we receive is “what medical marijuana products are available in Australia?”, as the Cannabis Clinics usually keep this secret.
After interviewing Cannabis Clinics about their processes, we found that the majority of medicines prescribed are oils, oral sprays or patches. However, there are still many options for dry bud (flowers) that you can use in a vaporiser.
Cannabis indica and Sativa plant both contain anywhere from eighty to hundred cannabinoids; however, both genetics and how they are grown can dramatically change the ratios of these cannabinoids in the plants.
Each one chemical in the plant can have a different effect on the body, making it all the more dangerous to seek illegal stains without the proper medical rules and regulations.
Cannabinoids worth through the endocannabinoid system is a unique communications system found in the brain and body of many species.
Cannabinoids produce their effects by interacting with specific receptors on the cells in your body, similar to commonly prescribed drugs such as SSRIs and analgesics.
When the receptor on the cells is either activated or deactivated, the function of the cell changes accordingly. Depending on where the cell is and what type of cell it is determined the effect it has on the body.
Delta9-tetrahydrocannabinol (Δ9-THC) and cannabidiol (CBD) are the two main cannabinoids for pharmaceutical use so far, with hopefully more to be discovered as research progresses.
THC is the “psychoactive” element in the cannabis plant and the main active ingredient in the anti-nausea, appetite increase and pain management effects used in the treatment of symptoms.
CBD, on the other hand, has the opposite effect and is believed to moderate THC with its anti-psychoactive effect.
Therefore, its believed CBD can negate the negative effects that people can experience from THC, such as anxiety & paranoia (5).
As a result of this, doctors can choose THC and CBD levels that are tailored for their particular patient, enhancing symptom relief and controlling for side effects.
CBD research is being conducted for its potential medicinal properties to treat disorders such as epilepsy, schizophrenia, type 2 diabetes, inflammatory bowel disease and many more (6).
Additionally, disorders such as anxiety and their interactive effect with CBD are being actively studied with promising results (7)
What risks does medical marijuana have?
The number one danger with medical marijuana is with smoking.
Smoking, in general, is a particularly harmful way of taking cannabis and therefore smoking cannabis is not recommended by health authorities.
Medical cannabis is consumed in a variety of safer ways, such as oils, oromucosal sprays and pills.
Unlike smoking, alternative methods allow doctors to control both the dose and ratios of THC & CBD in a more therapeutic manner giving the best treatment to the patient.
The NSW Government has established the Centre for Medicinal Cannabis Research and Innovation to further the understanding of cannabis and cannabis products for therapeutic purposes, and support evidence-based innovation.
Read more about the NSW situation at (Click Here).
Queensland is making the use of approved medicinal cannabis products possible as a treatment for certain conditions when the patient has already tried the conventional treatments available for their health or symptoms, and these have failed or cause intolerable side-effects.
Read more about the QLD situation at (Click Here).
The Tasmanian Government has developed a medical cannabis controlled access scheme (CAS).
The scheme will allow relevant medical specialists to be authorised to prescribe medical cannabis (unregistered cannabinoid products) in limited circumstances where conventional treatment has been unsuccessful.
Read more about the situation in Tasmania at (Click Here).
A patient living in the Northern Territory must access medicines containing cannabinoids through a Northern Territory doctor who is authorised under the Special Access or Authorised Prescriber Schemes administered by the Therapeutic Goods Administration.
Read more about the situation in the Northern Territory at (Click Here).
James is an experienced writer and legal cannabis advocate in Australia. He answers all the questions about business, legalisation and medicinal cannabis.
Disclaimer: Cannabis Place are not doctors and we recommend consulting health professionals for accurate information. This site may contain information regarding drugs. This content is designed for an 18+ audience. Click here for our full disclaimer